PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
0.8533
+0.0201 (2.41%)
Jan 5, 2026, 4:00 PM EST - Market closed
PDS Biotechnology Market Cap
PDS Biotechnology has a market cap or net worth of $46.69 million as of January 6, 2026. Its market cap has decreased by -35.49% in one year.
Market Cap
46.69M
Enterprise Value
38.46M
1-Year Change
-35.49%
Ranking
Category
Stock Price
$0.85
Market Cap Chart
Since March 18, 2019, PDS Biotechnology's market cap has increased from $45.51M to $46.69M, an increase of 2.59%. That is a compound annual growth rate of 0.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 45.59M | 8.24% |
| Dec 31, 2025 | 42.12M | -30.92% |
| Dec 31, 2024 | 60.98M | -60.56% |
| Dec 29, 2023 | 154.61M | -58.92% |
| Dec 30, 2022 | 376.31M | 63.37% |
| Dec 31, 2021 | 230.35M | 383.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |